Mayookha Mitra-Majumdar

Statistics

Publications

Citations

165

H-Index

Active since

2020

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

Yale University

Kaiser Permanente

Mayookha Mitra-Majumdar is an author at Brigham and Women's Hospital specializing in drug approval processes, cohort study investigation, and pharmacy.

ORCID

Publications per year

2020–2022

Publications

An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19

Aaron S. Kesselheim, Jonathan J. Darrow, Martin Kulldorff et al. · Health Affairs · 2020 · 55 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Reporting bias in clinical trials: Progress toward transparency and next steps

Mayookha Mitra-Majumdar, Aaron S. Kesselheim · PLoS Medicine · 2022 · 39 citations · Full text

Public Health, Biostatistics, Clinical Trial Regulation +11

Analysis of Supportive Evidence for US Food and Drug Administration Approvals of Novel Drugs in 2020

Mayookha Mitra-Majumdar, Simon J. Gunter, Aaron S. Kesselheim et al. · JAMA Network Open · 2022 · 28 citations · Full text

Pharmacy, Pharmacology, Clinical Pharmacology +16

Evidence at time of regulatory approval and cost of new antibiotics in 2016-19: cohort study of FDA approved drugs

Mayookha Mitra-Majumdar, John H. Powers, Beatrice L. Brown et al. · BMJ Medicine · 2022 · 20 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacology +15

A Multi-modal Approach to Evaluate the Impact of Risk Evaluation and Mitigation Strategy (REMS) Programs

Ameet Sarpatwari, Mayookha Mitra-Majumdar, Katsiaryna Bykov et al. · Drug Safety · 2021 · 12 citations

Management, Risk Management, Strategy +16

1–5 of 6